论文信息 - Pilot study of veliparib (ABT-888) with temozolomide (TMZ) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). - 字舞流文

Pilot study of veliparib (ABT-888) with temozolomide (TMZ) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

V. Giranda | M. Carducci | M. Hussain | S. Slovin | J. Alumkal | J. Cetnar | E. McKeegan | E. Litvinovich | B. Chyla | J. Qian | R. Hetman | B. Desai